HealthEquity (NASDAQ:HQY) Hits New 52-Week High – Here’s Why

Shares of HealthEquity, Inc. (NASDAQ:HQY) hit a new 52-week high on Wednesday . The stock traded as high as $106.42 and last traded at $104.79, with a volume of 49197 shares trading hands. The stock had previously closed at $104.97.

Wall Street Analyst Weigh In

A number of equities analysts recently weighed in on HQY shares. BMO Capital Markets upgraded shares of HealthEquity from a “market perform” rating to an “outperform” rating and lifted their price objective for the company from $85.00 to $105.00 in a research report on Thursday, April 9th. KeyCorp restated an “overweight” rating on shares of HealthEquity in a research report on Tuesday, May 26th. Wall Street Zen upgraded shares of HealthEquity from a “hold” rating to a “buy” rating in a research note on Saturday, July 25th. Royal Bank Of Canada lifted their target price on shares of HealthEquity from $100.00 to $108.00 and gave the company an “outperform” rating in a report on Wednesday, June 3rd. Finally, Wells Fargo & Company set a $111.00 price target on shares of HealthEquity in a research note on Monday, June 1st. Eleven analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $110.93.

HealthEquity Trading Down 0.7%

The business has a 50-day moving average of $92.42 and a 200 day moving average of $85.41. The stock has a market cap of $8.71 billion, a PE ratio of 39.03, a PEG ratio of 1.75 and a beta of 0.21. The company has a debt-to-equity ratio of 0.46, a quick ratio of 3.44 and a current ratio of 3.44.

HealthEquity (NASDAQ:HQY) last announced its earnings results on Thursday, May 28th. The company reported $1.24 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.11 by $0.13. HealthEquity had a net margin of 17.25% and a return on equity of 14.75%. The firm had revenue of $354.64 million for the quarter, compared to analyst estimates of $352.02 million. The business’s revenue for the quarter was up 7.2% on a year-over-year basis. HealthEquity has set its FY 2027 guidance at 2.880-2.950 EPS. Equities research analysts predict that HealthEquity, Inc. will post 3.92 EPS for the current fiscal year.

Insiders Place Their Bets

In other HealthEquity news, Director Gayle Furgurson Wellborn sold 2,439 shares of the firm’s stock in a transaction dated Thursday, May 28th. The stock was sold at an average price of $90.00, for a total value of $219,510.00. Following the transaction, the director directly owned 19,733 shares of the company’s stock, valued at $1,775,970. This trade represents a 11.00% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Delano Ladd sold 7,500 shares of the business’s stock in a transaction that occurred on Thursday, May 28th. The stock was sold at an average price of $90.00, for a total value of $675,000.00. Following the transaction, the executive vice president directly owned 91,141 shares in the company, valued at $8,202,690. This trade represents a 7.60% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 17,905 shares of company stock worth $1,651,280 over the last three months. 1.60% of the stock is owned by insiders.

Institutional Investors Weigh In On HealthEquity

A number of hedge funds have recently bought and sold shares of HQY. Acumen Wealth Advisors LLC acquired a new stake in shares of HealthEquity during the fourth quarter worth approximately $27,000. Aster Capital Management DIFC Ltd acquired a new stake in HealthEquity in the fourth quarter valued at $28,000. Caitong International Asset Management Co. Ltd raised its holdings in HealthEquity by 1,723.5% in the fourth quarter. Caitong International Asset Management Co. Ltd now owns 310 shares of the company’s stock valued at $28,000 after acquiring an additional 293 shares in the last quarter. Leonteq Securities AG boosted its stake in HealthEquity by 159.9% during the 1st quarter. Leonteq Securities AG now owns 382 shares of the company’s stock valued at $32,000 after acquiring an additional 235 shares during the last quarter. Finally, Axiom Investment Management LLC bought a new position in HealthEquity during the 1st quarter valued at $33,000. Institutional investors and hedge funds own 99.55% of the company’s stock.

HealthEquity Company Profile

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.